<div id="readability-page-1"><div><p>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that Pursuant to the terms of the CQ Pharma Mutual Supply Framework Agreement, the relevant member(s) of the Group and the relevant member (s) of the CQ Pharma Holdings Group will from time to time during the term of the CQ Pharma mutual Supply Framework Agreement engage in discussions. Once the principal terms of the Fosun Pharma Services transactions have been agreed, the relevant member(s&#34;) shall enter into specific service agreements to set out the detailed terms and conditions of the relevant Fosun Pharma Services transactions. The price at which the Fosun Pharma Services are provided shall be determined between the parties based on arm's-length negotiation on normal commercial terms with reference to (i) content of the specific services, and (ii) price of same type of or similar services provided on the market, and such prices and other terms on which the Group may provide the same type of services to independent third parties in comparable scale and form.</p><p>Pursuant to the terms the CQ Pharma Mutual Supply framework Agreement, the relevant member('s) of the Group and the applicable member(s) of the CQ Pharmaceutical Holdings Group will from time to time during the term of the C Q Pharma Mutual Supply Framework Agreement engage in discussions; Once the principal terms of the CQ Pharma Services transactions have been agreed; the relevant member(s) shall enter into specific service agreements To set out the detailed terms and condition of the relevant CQ Pharma Services transactions. The price At which the CQ Pharma Services are provided shall be determination between the parties based on arm 's-length negotiation on normal commercial Terms with reference to (i) nature, specification and volume of the products; (ii) prices approved by the local pricing authorities, if and where applicable; and (iii) market price of the products (or same type of products on the market), and the prices and other terms of the products shall be similar to the prices and other terms on which The Group may provide such products to independent third parties in comparable scales. With respect to the medical services, medical examination services such as body check and health risk assessment and other related services, diagnosis testing services and pharmaceutical industry consulting services to be provided by the Group to Fosun International and/or its associates, the service fees shall be determined between the parties based on arm 's-length negotiations on normal commercial terms with reference To (i) nature of the medical services and relevant pharmaceutical industry consulting services; (ii) rules and regulations on pricing by market adjustment promulgated by the relevant competent authority in relation to non-governmental medical institutions in the PRC and the applicable medical code set and pricing system commonly used in the industry, if and where applicable; (iii) relevant charging standards of same type of or similar industry consulting services provided by third parties; and (iv) the market supply and demand situation, and the brand positioning, and the service fees and other terms shall be similar to the service fees and other terms on which the group may provide such services to independent third parties in similar scale and form.</p><p>Pricing basis and policy of products and services to be provided and supplied by Fosun International and/or its associates.</p></div></div>

复星医药

<p>上海复星医药股份有限公司宣布了复星医药服务的定价依据和政策。价格将通过基于服务内容、市场价格和提供给第三方的条款的公平谈判来确定。该协议涵盖医疗服务、检查服务、诊断检测和咨询服务，费用将根据行业标准和市场情况设定</p>

上海复星医药股份有限公司公布了复星医药服务的定价基础和政策